Larry Green

Larry Green, Ph.D., is the Chief Executive Officer of AlivaMab Discovery Services and co-inventor of the AlivaMab® Mouse. He also serves as Chief Executive Officer of Ablexis, LLC. Larry has a quarter century of experience in designing, building, and using antibody drug discovery platforms, which has resulted in seven approved antibody drugs and multiple others in clinical trials. He is an inventor of over 60 US patents covering therapeutic product candidates and immunoglobulin transgenic mice, including the XenoMouse® platform (Abgenix/Amgen) and the AlivaMab Mouse platform (Ablexis), plus dozens of issued patents in other geographies. He has served as a founder of three companies, Abgenix, Inc. (founded 1996, acquired by Amgen, Inc. in 2006), Ablexis, LLC (founded 2009, acquired by Deerfield Management Company in 2018), and AlivaMab Discovery Services, LLC (founded 2018). He holds a Ph.D. in molecular and cellular biology from the University of Wisconsin-Madison and a BSc with honors in chemistry from the University of Kentucky.